Carmen Rousseeuw
About Carmen Rousseeuw
Carmen Rousseeuw is a Clinical Research Manager with extensive experience in the field, currently serving as Associate Director of Clinical Research at FirstWave Clinical Consultancy since 2014. She holds a Master's degree in Biomedical Sciences from the University of Antwerp and has worked in various roles across multiple organizations in Belgium.
Current Role at BioSense Webster
Carmen Rousseeuw serves as the Clinical Research Manager at BioSense Webster, a position she has held since 2012. In this role, she oversees clinical research initiatives and contributes to the advancement of medical technologies. Her work involves coordinating clinical trials and ensuring compliance with regulatory standards. Rousseeuw's extensive experience in clinical research supports her leadership in this capacity.
Professional Experience in Clinical Research
Carmen Rousseeuw has accumulated significant experience in the field of clinical research. Prior to her current role at BioSense Webster, she worked as a Clinical Research Consultant at Mediconsult from 2010 to 2014. She also held positions as a Consultant Project Leader at Cordis and as a Clinical Research professional at Celyad. Additionally, Rousseeuw served as a Study Coordinator at ZNA for one year and worked in medical imaging and research at UZA for three years.
Educational Background in Biomedical Sciences
Carmen Rousseeuw studied Biomedical Sciences at the University of Antwerp, where she completed her Master's degree from 1999 to 2003. This educational foundation provided her with essential knowledge and skills applicable to her career in clinical research. Rousseeuw also pursued studies at Cevora, further enhancing her expertise in the field.
Tenure at FirstWave Clinical Consultancy
Since 2014, Carmen Rousseeuw has been serving as the Associate Director of Clinical Research at FirstWave Clinical Consultancy. In this role, she has contributed to various clinical projects and has played a key part in the consultancy's research strategies. Her leadership in this position reflects her commitment to advancing clinical research practices.